Last reviewed · How we verify
Rocuronium Injection
At a glance
| Generic name | Rocuronium Injection |
|---|---|
| Sponsor | Tang-Du Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults (PHASE2)
- Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients (PHASE4)
- Efficacy and Safety of Ciprofol for General Anaesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement (PHASE4)
- The Impact of Intraperitoneal Spray Combined With Intravenous Lidocaine on Postoperative Pain After Myomectomy (NA)
- Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery (NA)
- Oliceridine Dose for Tracheal Intubation Hemodynamic Elevation: Up-and-Down Trial (NA)
- Perioperative GDNF as a Predictive Factor for Postoperative Delirium and Adverse Neurological Outcomes in Pediatric Surgery (NA)
- Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rocuronium Injection CI brief — competitive landscape report
- Rocuronium Injection updates RSS · CI watch RSS
- Tang-Du Hospital portfolio CI